AU2408602A - Indole derivatives and use thereof in medicines - Google Patents
Indole derivatives and use thereof in medicinesInfo
- Publication number
- AU2408602A AU2408602A AU2408602A AU2408602A AU2408602A AU 2408602 A AU2408602 A AU 2408602A AU 2408602 A AU2408602 A AU 2408602A AU 2408602 A AU2408602 A AU 2408602A AU 2408602 A AU2408602 A AU 2408602A
- Authority
- AU
- Australia
- Prior art keywords
- hydrogen
- hydroxy
- medicines
- indole derivatives
- integer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229940079593 drug Drugs 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title abstract 2
- 150000002475 indoles Chemical class 0.000 title abstract 2
- 229940054051 antipsychotic indole derivative Drugs 0.000 title 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 4
- 229910052739 hydrogen Inorganic materials 0.000 abstract 4
- 239000001257 hydrogen Substances 0.000 abstract 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 3
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 101100244562 Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) oprD gene Proteins 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 108700023159 delta Opioid Receptors Proteins 0.000 abstract 1
- 102000048124 delta Opioid Receptors Human genes 0.000 abstract 1
- 125000001153 fluoro group Chemical group F* 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000356382 | 2000-11-22 | ||
| PCT/JP2001/010249 WO2002042309A1 (en) | 2000-11-22 | 2001-11-22 | Indole derivatives and use thereof in medicines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2408602A true AU2408602A (en) | 2002-06-03 |
Family
ID=18828643
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2408602A Pending AU2408602A (en) | 2000-11-22 | 2001-11-22 | Indole derivatives and use thereof in medicines |
| AU2002224086A Ceased AU2002224086B8 (en) | 2000-11-22 | 2001-11-22 | Indole derivatives and use thereof in medicines |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002224086A Ceased AU2002224086B8 (en) | 2000-11-22 | 2001-11-22 | Indole derivatives and use thereof in medicines |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6770654B2 (enExample) |
| EP (1) | EP1342723B1 (enExample) |
| JP (1) | JP4292738B2 (enExample) |
| KR (1) | KR20030053530A (enExample) |
| CN (1) | CN1247591C (enExample) |
| AT (1) | ATE402179T1 (enExample) |
| AU (2) | AU2408602A (enExample) |
| CA (1) | CA2427931A1 (enExample) |
| DE (1) | DE60135016D1 (enExample) |
| ES (1) | ES2311034T3 (enExample) |
| WO (1) | WO2002042309A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1424337A1 (en) * | 2002-11-26 | 2004-06-02 | Solvay Pharmaceuticals GmbH | 4-hydroxy derivatives of 5,6,9,10-tetrahydro-10-((2-methyl-1h-imidazol-1-yl)methyl)-4h-pyrido-(3,2,1-jk)-carbazol-11(8h)-one |
| CN1758912A (zh) * | 2003-03-07 | 2006-04-12 | 东丽株式会社 | 药物·物质依赖治疗药 |
| US20060069086A1 (en) * | 2004-09-23 | 2006-03-30 | Alexander Michalow | Methods for regulating neurotransmitter systems by inducing counteradaptations |
| WO2006126529A1 (ja) | 2005-05-25 | 2006-11-30 | Shionogi & Co., Ltd. | ６，７－不飽和－７－カルバモイル置換モルヒナン誘導体 |
| WO2008001859A1 (fr) * | 2006-06-30 | 2008-01-03 | School Juridical Person Kitasato Gakuen | AGONISTE DES RÉCEPTEURS δ DES OPIOÏDES |
| EP2149370A1 (en) | 2008-07-31 | 2010-02-03 | Neuroscienze Pharmaness S.C. A R.L. | Diazabicyclic compounds and microemulsions thereof |
| IT1390848B1 (it) | 2008-07-31 | 2011-10-19 | Neuroscienze Pharmaness S C A R L | Composti farmaceutici |
| IT1396951B1 (it) | 2009-12-18 | 2012-12-20 | Neuroscienze Pharmaness S C A R L | Composti farmaceutici |
| EP3761982B1 (en) | 2018-03-08 | 2024-10-09 | Victoria Link Ltd | Use of nalfurafine for the treatment of demyelinating diseases |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3123080B2 (ja) | 1995-09-26 | 2001-01-09 | 東レ株式会社 | 「インドール誘導体およびその医薬用途」 |
-
2001
- 2001-11-22 KR KR10-2003-7006870A patent/KR20030053530A/ko not_active Ceased
- 2001-11-22 EP EP01997196A patent/EP1342723B1/en not_active Expired - Lifetime
- 2001-11-22 CA CA002427931A patent/CA2427931A1/en not_active Abandoned
- 2001-11-22 JP JP2001357400A patent/JP4292738B2/ja not_active Expired - Fee Related
- 2001-11-22 DE DE60135016T patent/DE60135016D1/de not_active Expired - Fee Related
- 2001-11-22 WO PCT/JP2001/010249 patent/WO2002042309A1/ja not_active Ceased
- 2001-11-22 ES ES01997196T patent/ES2311034T3/es not_active Expired - Lifetime
- 2001-11-22 AT AT01997196T patent/ATE402179T1/de not_active IP Right Cessation
- 2001-11-22 AU AU2408602A patent/AU2408602A/xx active Pending
- 2001-11-22 AU AU2002224086A patent/AU2002224086B8/en not_active Ceased
- 2001-11-22 US US10/432,011 patent/US6770654B2/en not_active Expired - Fee Related
- 2001-11-22 CN CNB018221122A patent/CN1247591C/zh not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| KR20030053530A (ko) | 2003-06-28 |
| CA2427931A1 (en) | 2002-05-30 |
| ES2311034T3 (es) | 2009-02-01 |
| AU2002224086B1 (en) | 2006-11-16 |
| ATE402179T1 (de) | 2008-08-15 |
| EP1342723B1 (en) | 2008-07-23 |
| EP1342723A4 (en) | 2005-02-09 |
| CN1486321A (zh) | 2004-03-31 |
| AU2002224086B8 (en) | 2002-06-03 |
| US6770654B2 (en) | 2004-08-03 |
| WO2002042309A1 (en) | 2002-05-30 |
| EP1342723A1 (en) | 2003-09-10 |
| DE60135016D1 (de) | 2008-09-04 |
| CN1247591C (zh) | 2006-03-29 |
| JP2002220391A (ja) | 2002-08-09 |
| US20040019071A1 (en) | 2004-01-29 |
| JP4292738B2 (ja) | 2009-07-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA02012034A (es) | Derivados de tiofeno utiles como agentes anticancerosos. | |
| ATE260263T1 (de) | Heteroaromatische bizyklische verbindungen mit antikrebswirkung | |
| GB9914486D0 (en) | Medicaments | |
| PT1452524E (pt) | Derivado de 2-oxo-1-pirrolidina e suas utilizações farmacêuticas | |
| MY132073A (en) | Thienopyrimidine and thienopyridine derivatives useful as anticancer agents | |
| IL148384A0 (en) | Glucopyranosyloxypyrazole derivatives, medicinal compositions containing the same and intermediates in the production thereof | |
| IL138719A0 (en) | Aminocyclohexyl ether derivatives and pharmaceutical compositions containing the same | |
| ATE386725T1 (de) | Heterocyclylverbindungen | |
| YU56302A (sh) | Derivati 8,8a-dihidro-indeno/1,2-d/taizola, koji su supstituisani u 8a-položaju,postupak za njihovu proizvodnju i njihova primena kod leka npr.kao anorektičnog sredstva | |
| MXPA02009643A (es) | Sintesis acortada de derivados de 3,3-diarilpropilamina. | |
| BG104069A (en) | 2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-1h-indole derivatives interacting with the dopamine d4 receptor | |
| IL159880A0 (en) | Arylsulfonyl derivatives with 5-ht6 receptor affinity | |
| EP1057813A4 (en) | INDOLE DERIVATIVES AND MEDICAL COMPOSITIONS CONTAINING THEM | |
| AU2408602A (en) | Indole derivatives and use thereof in medicines | |
| PL359415A1 (en) | Oxadiazole derivatives having anticancer effects | |
| AU6729600A (en) | Novel isoindole derivatives | |
| EP1238970A4 (en) | CYCLOAMINE CCR5 RECEPTOR ANTAGONISTS | |
| WO2001010860A3 (en) | Quinazolinone and azaquinazolinone derivatives | |
| MXPA05014127A (es) | Uso de derivados de biciclo[2.2.1]heptano para la preparacion de composiciones farmaceuticas neuroprotectoras. | |
| AU2001295837A1 (en) | Aminoalkylpyrrolidine serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their synthesis | |
| AU5535900A (en) | Complexes of paroxetine, with cyclodextrins or cyclodextrin derivatives | |
| MX2009001572A (es) | Derivados de arilpiperazina y usos de los mismos. | |
| EP1151993A4 (en) | CYCLIC AMINE DERIVATIVES AND THEIR APPLICATIONS | |
| MXPA04002784A (es) | Sales farmaceuticamente aceptables de 20(s)-camptotecinas. | |
| IL169577A0 (en) | Oligosaccharide derivatives and pharmaceutical compostions containing the same |